Deals
Maravai Soars After Reported Takeover Offer from Repligen
This article is for subscribers only.
Maravai LifeSciences Holdings Inc. shares soared after a report that the drug research and manufacturing firm received a takeover offer from Repligen Corp.
Maravai shares rose as much as 25% on Friday to $9.95 after Reuters reported the approach, raising its market valuation to about $2.6 billion from $2.08 billion. Repligen shares were down 11% as of 2:58 p.m. in New York.